FDA has approved MOVANTIKsup/sup (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist drug for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. Opioids play an important role in chronic pain relief and millions of patients are treated with them in the United States each year. They work by binding to mu-receptors in the central nervous system, ...
Read MoreYou have just read an article categorized health
titled New Treatment for Opioid Induced Constipation in Patients With Chronic Non-cancer Pain.
Written by:
editor - Saturday, November 1, 2014
There are currently no comments for "New Treatment for Opioid Induced Constipation in Patients With Chronic Non-cancer Pain"
Post a Comment